A literature search of new studies clarifies, refutes, and expands on previous recommendations for managing new and established CIPN in patients treated with cytotoxic agents.
Ibrutinib-mediated macrophage inhibition may underlie an increased risk of invasive fungal infection in patients with CLL treated with this agent.
This study is the first placebo-controlled clinical trial to investigate a treatment for MRONJ in patients for whom the condition is established.
One objective underlying development of these guidelines was to identify research gaps regarding the management of cancer treatment–related hot flashes.
Risk-adapted therapy effectively prevents fungal infections and reduces neurotoxicity in children with leukemia.
The odds of developing a surgical infection after cytoreductive surgery for ovarian cancer more than doubled in women who had bowel resection or repair.
Long-term survivors of childhood cancers with exercise intolerance may have emotional distress, less social role achievement, and worse HRQOL.
A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.
A discussion on the genetic influence of single nucleotide polymorphisms on cancer pain and their potential to assist pain management in patients with cancer.
Physicians noted that patients receiving best supportive care were more likely to be interested in low-intensity treatments if the risk for side effects was lower.
